Envision Healthcare Corporation (EVHC) Position Boosted by GHP Investment Advisors Inc.
GHP Investment Advisors Inc. lifted its position in shares of Envision Healthcare Corporation (NYSE:EVHC) by 21.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 23,919 shares of the company’s stock after buying an additional 4,234 shares during the period. GHP Investment Advisors Inc.’s holdings in Envision Healthcare Corporation were worth $1,075,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Commonwealth Bank of Australia raised its stake in Envision Healthcare Corporation by 24.3% during the second quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after purchasing an additional 410 shares during the period. LMR Partners LLP purchased a new position in Envision Healthcare Corporation during the second quarter worth approximately $205,000. Palisade Capital Management LLC NJ purchased a new position in Envision Healthcare Corporation during the third quarter worth approximately $229,000. Cutter & CO Brokerage Inc. raised its stake in Envision Healthcare Corporation by 11.1% during the second quarter. Cutter & CO Brokerage Inc. now owns 3,668 shares of the company’s stock worth $230,000 after purchasing an additional 367 shares during the period. Finally, HighTower Advisors LLC raised its stake in Envision Healthcare Corporation by 5.6% during the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock worth $274,000 after purchasing an additional 240 shares during the period.
Envision Healthcare Corporation (NYSE EVHC) traded down $0.75 on Friday, reaching $24.98. 278,944 shares of the company were exchanged, compared to its average volume of 2,074,261. The firm has a market cap of $2,995.28, a price-to-earnings ratio of 7.65, a price-to-earnings-growth ratio of 0.65 and a beta of 0.69. Envision Healthcare Corporation has a 1-year low of $24.62 and a 1-year high of $74.75. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01.
Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. Envision Healthcare Corporation’s revenue for the quarter was up 142.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.13 earnings per share. analysts forecast that Envision Healthcare Corporation will post 2.56 earnings per share for the current year.
Envision Healthcare Corporation announced that its board has authorized a share buyback plan on Monday, September 18th that permits the company to buyback $250.00 million in shares. This buyback authorization permits the company to repurchase up to 4.5% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.
WARNING: “Envision Healthcare Corporation (EVHC) Position Boosted by GHP Investment Advisors Inc.” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/10/envision-healthcare-corporation-evhc-position-boosted-by-ghp-investment-advisors-inc.html.
A number of equities analysts have weighed in on EVHC shares. Robert W. Baird reaffirmed a “buy” rating and set a $70.00 price target on shares of Envision Healthcare Corporation in a research note on Tuesday, October 17th. Oppenheimer Holdings, Inc. cut their price target on shares of Envision Healthcare Corporation from $77.00 to $40.00 and set an “outperform” rating on the stock in a research note on Thursday, November 2nd. Cantor Fitzgerald downgraded shares of Envision Healthcare Corporation from an “overweight” rating to a “neutral” rating and set a $30.00 price target on the stock. in a research note on Wednesday, November 1st. Bank of America Corporation downgraded shares of Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $32.00 price target on the stock. in a research note on Thursday, November 2nd. Finally, Jefferies Group LLC set a $71.00 price target on shares of Envision Healthcare Corporation and gave the stock a “buy” rating in a research note on Thursday, August 24th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $49.21.
Envision Healthcare Corporation Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.